"Das Josephs-Hospital, im Mittelpunkt des Städtedreiecks Münster, Osnabrück und Bielefeld, ist akademisches Lehrkrankenhaus der Westfälischen ­Wilhelms-­Universität Münster und ein leistungsstarkes und ­modernes Akutkrankenhaus. Unser interdisziplinäres Team leistet jährlich in rund 30.000 stationären und ambulanten Fällen ­medizinische und pflegerische Arbeit auf hohem Niveau. Dank ­kontinuierlich umgesetzter Modernisierungsmaßnahmen und Investitionen in moderne Medizintechnik bieten wir unseren Patienten hervorragende Therapie- und unseren Mitarbeitern sehr gute Rahmenbedingungen."

During the past decade, Josephs-Hospital Warendorf conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Josephs-Hospital Warendorf" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Cogentus Pharmaceuticals" with 1 trials sponsored, "Gynesonics" with 1 trials sponsored, "Institut für Klinisch-Kardiovaskuläre Forschung GmbH" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Josephs-Hospital Warendorf" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "BMBf (Federal Ministry of Education and Research)" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Josephs-Hospital Warendorf" are "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Acute Coronary Syndrome" (1 trials), "Atrial Fibrillation" (1 trials) and "Myocardial Infarction" (1 trials). Many other conditions were trialed in "Josephs-Hospital Warendorf" in a lesser frequency.

Most popular intervention types in "Josephs-Hospital Warendorf" are "Drug" (4 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials), "Placebo" (2 trials), "Apixaban" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials) and "Parenteral heparin and/or oral Vitamin K antagonist" (1 trials). Other intervention names were less common.

The vast majority of trials in "Josephs-Hospital Warendorf" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Josephs-Hospital Warendorf". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Josephs-Hospital Warendorf, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Josephs-Hospital Warendorf, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Josephs-Hospital Warendorf has several departments that took part in Clinical trials: "Josephs-Hospital Warendorf Med. Klinik II, Kardiologie/Angiologie" - 2 trials